Cryo-Cell International, Inc. Common Stock - Çeyreklik Bilanço (NYSE:CCEL) | MetaTrader

Tam grafiği aç Full chart

Cryo-Cell International, Inc. Common Stock

Cryo-Cell International, Inc. is a cord blood bank. It was founded by Dan Richard in 1989. Cryo-Cell International is the first private cord blood bank to separate and store stem cells. Cryo-Cell is headquartered outside of Tampa, in Oldsmar, Florida. In January 1997, the Company's stock began trading on the NASDAQ Small Cap market under symbol CCEL.

Haberler

NYSE, Cryo-Cell’in uyum planını kabul etti

Cryo-Cell, FACT akreditasyonunu 2029’a kadar yeniledi

CryoCell International kazancı $0,10 ile beklentilere göre daha iyi, kâr ise beklentilere göre yüksek

Cryo-Cell, NYSE American’dan uyumsuzluk bildirimi aldı

Cryo-Cell receives NYSE American non-compliance notice

Cryo-Cell International kredi anlaşmasını değiştirdi, kredi şartlarını ve vade tarihini düzenledi

Cryo-Cell International amends credit agreement, adjusts loan terms and maturity

CryoCell International kazancı $0,13 ile beklentilere göre daha iyi, kâr ise beklentilere göre düşük

CryoCell International earnings beat by $0.13, revenue fell short of estimates

Cryo-Cell suspends quarterly dividend amid profitability concerns

CryoCell International earnings beat by $0.01, revenue fell short of estimates